The study by researchers of the Research Programme on Biomedical Informatics (GRIB) from Universitat Pompeu Fabra (UPF) and Hospital del Mar Medical Research Institute (IMIM) in Barcelona, Spain
Interim results of the Oxford Covid-19 vaccine trials found that the vaccine protects against symptomatic disease in 70 per cent of cases with vaccine efficacy of 62 per cent for those given two full doses, and of 90 per cent in those given a half then a full dose.
